Dr. Reddy’s gets 2 USFDA observations for Srikakulam facility

05 Apr 2017 Evaluate

Dr. Reddy’s Laboratories’ API manufacturing plant at Srikakulam in state of Andhra Pradesh has been audited by the US Food and Drug Administration (USFDA), and the audit has been completed on April 4, 2017. The company has been issued a Form 483 with 2 observations, which it is addressing.

Earlier, the company’s formulation manufacturing facility at Duvvada, Visakhapatnam, had been audited by the USFDA, and the audit had been completed on March 8, 2017. The company had been issued a Form 483 with 13 observations, which it was addressing.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.


Dr. Reddys Lab Share Price

1166.45 -9.10 (-0.77%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×